Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-1998 | 09-1998 | 06-1998 | 03-1998 | 12-1997 | |
Sales | 146,445 | 145,946 | 141,885 | 121,872 | 109,764 |
Cost of Goods | 52,140 | 56,630 | 54,780 | 45,100 | 41,843 |
Gross Profit | 94,310 | 89,310 | 87,100 | 76,770 | 72,542 |
Operating Expenses | 36,630 | 37,660 | 37,970 | 31,100 | 30,228 |
Operating Income | 57,815 | 52,286 | 49,915 | 45,772 | 38,536 |
Interest Expense | 2,900 | 2,750 | 1,410 | 0 | 0 |
Other Income | 8,555 | 4,324 | 3,665 | -16,202 | 7,692 |
Pre-tax Income | 63,470 | 53,860 | 52,170 | 29,570 | 46,228 |
Income Tax | 21,060 | 20,030 | 19,400 | 17,750 | 17,304 |
Net Income Continuous | 36,626 | 33,825 | 32,763 | 11,825 | 29,423 |
Net Income | $36,626 | $33,825 | $32,763 | $11,825 | $29,423 |
EPS Basic Total Ops | 0.40 | 0.37 | 0.36 | 0.13 | 0.33 |
EPS Basic Continuous Ops | 0.40 | 0.37 | 0.36 | 0.13 | 0.34 |
EPS Diluted Total Ops | 0.40 | 0.37 | 0.36 | 0.13 | 0.33 |
EPS Diluted Continuous Ops | 0.40 | 0.37 | 0.36 | 0.13 | 0.33 |
EBITDA(a) | $67,055 | $60,046 | $57,545 | $52,452 | $35,861 |